Chinese Clinical Trials Virtual Conference Agenda
|
|
10:00 a.m. – 10:10 a.m. |
Introduction to the Virtual Conference Chairperson, Gabriela Rossi, Principal Consultant, PAREXEL Consulting |
10:10 a.m. – 10:55 a.m. |
The Promise and Pitfalls of Conducting Clinical Trials in China – A Regulatory Perspective Attendees will:
Carolyn Leahy, Director, WRS-Emerging Markets, Pfizer Global Research & Development, Sandwich Laboratories, UK |
10:55 a.m. – 11:10 a.m. |
Break |
11:10 a.m. – 11:55 a.m. |
Human Subjects Protections Management in Clinical Trials in China: A Transnational Perspective Attendees will learn:
|
11:55 a.m. – 12:40 p.m. |
GCP Compliance for Clinical Trials: 5 Tips for Qualifying Investigators and Sites (prerecorded due to time difference in China) Attendees will learn:
Dr. Yan Wu, Medical Director, Biogen China |
12:40 p.m. – 1:40 p.m. |
Lunch Break |
1:40 p.m. – 2:25 p.m. |
US FCPA and UK Bribery Act Compliance: How A $100 Payment Could Wreck a Multi-million Dollar Drug or Device Clinical Trial Attendees will learn:
Marcus Asner, Partner, Arnold & Porter, New York |
2:25 p.m. – 3:10 p.m. |
Pan-Asian Clinical Strategies and Integration for Drug Development Attendees will learn:
Min Yue, Senior Consultant, PAREXEL Consulting, Indianapolis, IN |
3:10 p.m. – 3:20 p.m. |
Closing Comments and Adjournment Chairperson, Gabriela Rossi, Principal Consultant, PAREXEL Consulting, Boston, MA |